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Abstract Fluid infusion is one of the most common critical
care interventions, yet approximately 50 % of all fluid
interventions are unnecessary and potentially harmful. An
improved approach to identification of fluid responsiveness is
of clinical importance. Currently fluid responsiveness is most
frequently identified by blood pressure (BP) measurements or
a surrogate. However fluid responsiveness is simply the
increase in stroke volume (SV) associated with volume
expansion, and may not be reflected in BP or BP surrogates.
Guyton demonstrated that BP = CO x SVR, and it is know
that baroreceptor mediated autonomic nervous system regu-
lation of SV and SVR to preserve BP may mask significant
and critical changes in haemodynamics. Dr Pinsky in his
recent J Clin Monit Comput Editorial evaluated the relative
merits of pulse pressure variability (PPV) methods, a variant
on BP measurement, for assessment of fluid responsiveness
and promoted the use of physiologic challenges to augment
the applicability of PPV. However this guidance is only half
right. This letter reminds clinicians of the physiologic limi-
tations of PPV as a measure of fluid responsiveness, even
when combined with physiologic challenges, and recom-
mends the replacement of BP with SV measurements. The
combination of accurate Doppler measurement of SV and
physiologic challenges, as Dr Pinsky recommends, is a
physiologically rational and effective approach to identifi-
cation of fluid responsiveness with established evidence. The
direct monitoring of SV and SV changes has the potential to
improve a long standing critical care and anaesthetic
conundrum; when to give fluid and when to stop.
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1 Introduction
While we have the utmost respect for both the great
baseball philosopher Yogi Berra and Michael Pinsky, it
would seem that in Pinsky’s recent Editorial ‘‘It is amazing
what you can see if you look’’ on fluid responsiveness and
physiologic challenges, we have been provided with only
half the clues [1].
Dr Pinsky’s central point is that physiologic challenges
improve the effectiveness and applicability of PPV moni-
toring for identifying fluid responsiveness, and this is
incontestable. However basic physiology ultimately limits
the effectiveness of PPV monitoring for identification of fluid
responsiveness as Benes and others have observed [2, 3].
This editorial raises two questions related to physiology.
Does PPV approximate SVV, and is the change in PPV–
dPPV, equivalent to the change in SV–dSV, the definitive
measure of fluid responsiveness as demonstrated by Frank
and Starling?
While detection of fluid responsiveness by PPV is lim-
ited to approximately 2–51 % of ICU patients [2, 3], Pin-
sky suggests that dPPV before and after a dynamic
physiologic challenge can improve this applicability. This
may be possible, but we would argue that this is an
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unnecessarily complicated approach that appears designed
to compensate for the fundamental physiologic failings of
PPV rather than to simplify and improve the clinical pro-
cess of identifying fluid responsiveness.
Despite being a common intervention and clinical
conundrum, fluid responsiveness is defined quite simply;
fluid responsiveness is a change in SV associated with
volume expansion. Yet current methods of assessing fluid
responsiveness are predominantly based on surrogates
measures of BP—MAP, CVP, IVCd, RAP, PCWP and now
PPV. This persistent use of BP and its analogues, such as
PPV, to guide fluid therapy, may explain the persistent
observation that 50 % or more of all fluid infusions are
unnecessary, and potentially harmful [4].
No matter how hard we look at BP or its pressure sur-
rogates, with any number of trials of selected patient
cohorts, using any number of devices attached to fingers, or
inserted in arteries, and during whatever physiologic
challenges, ultimately the baroreceptor modulated Auto-
nomic Nervous System (ANS) ensures that we only see the
BP, and not the SV response!
Guyton demonstrated that BP = CO 9 SVR, thus any
correlation between BP (PPV) and CO (SVV) is dependent
on SVR remaining constant. While PPV may show some
correlation with SVV and fluid responsiveness in normal
stable patients, the dynamic beat to beat regulation of ven-
triculo-arterial coupling by the ANS precludes its applica-
tion in the dynamic circulation of sick patients. BP, the
product of CO(SV) and SVR, is effectively preserved in a
baroreceptor determined range by the ANS, so even sub-
stantial derangements of either CO/SV or SVR/Ea, will be
paradoxically regulated by the ANS to preserve BP. Espe-
cially in children, such compensation can effectively mask
significant underlying abnormalities of CO/SV and or SVR
which may require therapy [5]. If BP is used as a guide, then
appropriate therapy isn’t initiated until decompensation and
hypotensive shock occurs. This eventual fall in BP is a sign
that the ANS, and most likely the physician, has failed, and
explains the high mortality associated with hypotensive
shock!
This dynamic modulation of BP complicates the rela-
tionship between PPV and SVV, and prevents PPV from
accurately tracking CO(SV) and SVR, and thereby identi-
fying cardiovascular abnormalities discrete from BP. This
ensures that PPV is both a poor guide for fluid respon-
siveness, and an ineffective guide for inotropes and vaso-
active therapies.
From a physiologic stand point it is elementary that the
accurate measurement of SV is fundamental for the reliable
identification of fluid responsiveness, and that BP mea-
sures, including PPV, are therefore only useful insofar as
they correlate with SV or SVV, or those in whom ANS
regulation is relatively inactive.
Whilst Pinsky may challenge the retrospective method-
ology of Benes’ study, physiology, animal research and other
clinical studies support these findings of limited PPV
applicability.
In 2013 Bouchacourt et al. studied dynamic arterial
pressure surrogates, including PPV, to track SVV changes
during progressive induced hypovolemia in a rabbit model
of hemorrhage while increasing vasomotor tone with
phenylephrine [6]. They found that dynamic arterial pres-
sure indices, including PPV, were ineffective for detecting
fluid responsiveness, and did not reflect the extent of fluid
loss compared to SVV as the gold standard. This can be
explained by the ANS effectively up-regulating the SVR in
response to the decreased SV induced by the hypovolemia,
to preserve the BP, or BP = CO(SV) as Guyton observed.
Though PPV may have some application in detection of
fluid responsiveness in normal patients, the presence of any
source of disturbed or dynamic ventriculo-arterial cou-
pling, such as arrhythmia, vaso-active therapies, irregular
or complex respiration, and of course diseases with
dynamic effects on cardiac and vascular function, such as
sepsis, further inhibits the effectiveness and application of
PPV [2, 7]. In short the types of patients that require high
level haemodynamic monitoring are precisely the ones in
whom PPV is least effective. While the addition of autol-
ogous challenges may improve the 2-51 % feasibility
reported by Benes et al. and Mahjoub et al. [2, 3], PPV will
remain a physiologically ineffective method of detecting
fluid responsiveness in the majority of sick patients.
The limits of isolated pressure-based circulatory man-
agement have been further highlighted by Asfar et al. [8] in a
recent randomised control trial demonstrating that targeting
either a high or low BP range in septic shock patients pro-
duced no significant difference in outcomes. The ProCESS
trial also confirmed that various BP guided, fluid based
protocols were ineffective in reducing mortality outcomes in
septic shock from approximately 30 % [9.] So not only is BP
the wrong measure for detecting fluid responsiveness, but it
can only be applied in a small percentage of sick patients and
has generally modest effectiveness in guiding the complex
haemodynamics found in patients with sepsis.
Even if PPV had some applicability for identification of
fluid responsiveness, the reliability and reproducibility of
methods used for PPV measurements is poor. Pinsky’s own
work comparing three different arterial pulse pressure
methods (PiCCO, LiDCO, FloTrac) concluded that although
they all generally generated approximately the same mean
values, they often trended in different directions and could
not be used interchangeably [10]. de Wilde was even more
damning and after comparison of five arterial pulse pressure
contour technologies (LiDCO, PiCCO, BMeye, Hemac)
concluded that ‘‘none of the five pulse contour methods can
replace thermodilution with four equally spread measures
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over the ventilator cycle, even after calibration by a precise
thermodilution technique’’ [11]. These findings are further
proof of the veracity of Guyton’s observations.
Given the crucial physiologic, technical and clinical
limitations of PPV, why not really open our eyes, as Pinsky
exhorts, and observe fluid responsiveness by directly
measuring SV, and not the modulated surrogate BP? Well
validated Doppler technologies accurately measure both
SV and SVV, and are readily available to detect haemo-
dynamic abnormalities in sepsis and guide fluid, inotropes
and vasoactive therapies, and are noninvasive.
Doppler has an in vitro accuracy of 97 % measured
against ultrasonic transit time flow probes [12, 13]. A
comparison of transcutaneous Doppler (USCOM) with
surgically implanted transit time flow probes in dogs,
demonstrated a mean bias of 3 % and a precision of 13 %
[14]. While a similar comparison of flow probes with
USCOM in sheep over a sixfold CO range associated with
inotrope and vasoactive therapy demonstrated sensitivity to
5 % changes in SV [15], while in humans this sensitivity is
7.5–10 %. This high sensitivity to SV change provides
guidance of when to start fluid infusion, low SV and high
SVV, and also when to stop, at the point of optimisation
where additional fluid is no longer associated with an
increased SV.
Transoesophageal Doppler monitoring has the best
outcomes evidence of any technology for the management
of perioperative fluid guidance, with a recent meta-analysis
by the UK NHS Technical Adoption Centre reporting
results from 10 RCTs and 2 nonrandomised outcomes trials
that demonstrated improved mortality, morbidity and
reduced costs using transoesophageal Doppler (CardioQ)
for intra-operative fluid optimisation [16].
Combining accurate SV measures, in place of PPV, with
the physiologic challenges recommended by Pinsky, results
in a potent solution to the identification of cardiovascular
reserve and fluid responsiveness, even in patients in whom
PPV is otherwise excluded (AF, sepsis, on vasoactive
therapies, free breathing etc.). Thiel et al. demonstrated a
positive predictive value of 91 % for detection of fluid
responsiveness in unselected ICU patients using USCOM
measured SV changes associated with passive leg raising.
Of the 102 patients studied, 61 % were diagnosed with
sepsis, where both the SV and SVR can range from high,
normal to low, 18 % had cardiac arrhythmias, 56 % were
on vasopressors, 34 % were spontaneously breathing
(66 % ventilated) [4]. In children Deep et al. [17] have
identified novel haemodynamic features of sepsis and
septic shock and modified fluid, inotrope and vasoactive
therapy using USCOM flow based parameters to improve
outcomes.
While we totally agree with Dr Pinsky, and Yogi Berra,
that physiologic challenges are important tests to identify
cardiovascular reserve, only when combined with an
accurate measure of SV can we truly ‘‘see’’ the circulatory
changes they induce. Non-invasive and accurate monitor-
ing of SV at baseline and after intervention is the gold
standard for effective and personalised haemodynamic
monitoring. This physiologically rational approach is not
just effective for the identification of fluid responsiveness,
but also for detection of circulatory disease and guidance of
inotropes and vasoactive therapies, and can be applied in
adults and children across a range of diseases including
hypertension, heart failure and sepsis.
With regard to the application of PPV for identification
of fluid responsiveness, physiology and clinical evidence
are in agreement with both recommending we look else-
where, as Benes and Mahjoub concluded. While we agree
with Yogi Berra, it was Sherlock Holmes who gave us the
vital next clue for improving fluid management; ‘‘Watson,
You see, but you do not observe. The distinction is clear’’
[18]. And it is elementary—direct SV monitoring is critical
for improved management of fluid responsiveness.
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